E-MYCIN E Drug Patent Profile
✉ Email this page to a colleague
When do E-mycin E patents expire, and when can generic versions of E-mycin E launch?
E-mycin E is a drug marketed by Pharmacia And Upjohn and is included in one NDA.
The generic ingredient in E-MYCIN E is erythromycin ethylsuccinate. There are one hundred and three drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the erythromycin ethylsuccinate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for E-mycin E
A generic version of E-MYCIN E was approved as erythromycin ethylsuccinate by AZURITY on December 31st, 1969.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for E-MYCIN E?
- What are the global sales for E-MYCIN E?
- What is Average Wholesale Price for E-MYCIN E?
Summary for E-MYCIN E
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 54 |
| Patent Applications: | 1,569 |
| DailyMed Link: | E-MYCIN E at DailyMed |
US Patents and Regulatory Information for E-MYCIN E
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacia And Upjohn | E-MYCIN E | erythromycin ethylsuccinate | SUSPENSION;ORAL | 062198-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pharmacia And Upjohn | E-MYCIN E | erythromycin ethylsuccinate | SUSPENSION;ORAL | 062198-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
